Gastric Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2019-03-11
FDA Approved: TRAZIMERA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved TRAZIMERA (trastuzumab-qyyP) from Pfizer as an original biologics license application. It is a biosimilar to trastuzumab indica…